$3.94
0.020.51%
마지막 업데이트: Nov 19, 9:45 AM

The average analyst price target for Opus Genetics is $12.44, 215.7% above the current price. Of 16 analysts, 16 rate it Buy. Targets range from $5 to $20. The latest change came on Nov 11, 2026, when RBC Capital raised its price target on Opus Genetics from $9 to $11 and kept an Outperform rating.
Price Target Range — 8 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months